SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1552 5279 OR L773:1552 5260 "

Sökning: L773:1552 5279 OR L773:1552 5260

  • Resultat 31-40 av 522
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  •  
32.
  • Boada, Mercè, et al. (författare)
  • Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease : Results from the MOPEAD project
  • 2022
  • Ingår i: Alzheimer's and Dementia. - : Wiley. - 1552-5260 .- 1552-5279. ; 18:6, s. 1119-1127
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis. Methods: Four different strategies or RUNs were used: (a) a web-based (WB) prescreening tool, (2) an open house initiative (OHI), (3) a primary care–based protocol for early detection of cognitive decline (PC), and (4) a tertiary care–based pre-screening at diabetologist clinics (DC). Results: A total of 1129 patients at high risk of having prodromal AD or dementia were identified of 2847 pre-screened individuals (39.7%). The corresponding proportion for the different initiatives were 36.8% (WB), 35.6% (OHI), 44.4% (PC), and 58.3% (DC). Conclusion: These four complementary pre-screening strategies were useful for identifying individuals at high risk of having prodromal or mild AD.
  •  
33.
  •  
34.
  •  
35.
  •  
36.
  • Bocchetta, Martina, et al. (författare)
  • The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey.
  • 2015
  • Ingår i: Alzheimer's & Dementia. - : Wiley. - 1552-5279 .- 1552-5260. ; 11:2, s. 195-206
  • Tidskriftsartikel (refereegranskat)abstract
    • We investigated the use of Alzheimer's disease (AD) biomarkers in European Alzheimer's Disease Consortium centers and assessed their perceived usefulness for the etiologic diagnosis of mild cognitive impairment (MCI). We surveyed availability, frequency of use, and confidence in diagnostic usefulness of markers of brain amyloidosis (amyloid positron emission tomography [PET], cerebrospinal fluid [CSF] Aβ42) and neurodegeneration (medial temporal atrophy [MTA] on MR, fluorodeoxyglucose positron emission tomography [FDG-PET], CSF tau). The most frequently used biomarker is visually rated MTA (75% of the 37 responders reported using it "always/frequently") followed by CSF markers (22%), FDG-PET (16%), and amyloid-PET (3%). Only 45% of responders perceive MTA as contributing to diagnostic confidence, where the contribution was rated as "moderate". Seventy-nine percent of responders felt "very/extremely" comfortable delivering a diagnosis of MCI due to AD when both amyloid and neuronal injury biomarkers were abnormal (P < .02 versus any individual biomarker). Responders largely agreed that a combination of amyloidosis and neuronal injury biomarkers was a strongly indicative AD signature.
  •  
37.
  • Bollack, Ariane, et al. (författare)
  • Investigating reliable amyloid accumulation in Centiloids : Results from the AMYPAD Prognostic and Natural History Study
  • 2024
  • Ingår i: Alzheimer's and Dementia. - 1552-5260 .- 1552-5279. ; 20:5, s. 3429-3441
  • Tidskriftsartikel (refereegranskat)abstract
    • INTRODUCTION: To support clinical trial designs focused on early interventions, our study determined reliable early amyloid-β (Aβ) accumulation based on Centiloids (CL) in pre-dementia populations. METHODS: A total of 1032 participants from the Amyloid Imaging to Prevent Alzheimer's Disease–Prognostic and Natural History Study (AMYPAD-PNHS) and Insight46 who underwent [18F]flutemetamol, [18F]florbetaben or [18F]florbetapir amyloid-PET were included. A normative strategy was used to define reliable accumulation by estimating the 95th percentile of longitudinal measurements in sub-populations (NPNHS = 101/750, NInsight46 = 35/382) expected to remain stable over time. The baseline CL threshold that optimally predicts future accumulation was investigated using precision-recall analyses. Accumulation rates were examined using linear mixed-effect models. RESULTS: Reliable accumulation in the PNHS was estimated to occur at >3.0 CL/year. Baseline CL of 16 [12,19] best predicted future Aβ-accumulators. Rates of amyloid accumulation were tracer-independent, lower for APOE ε4 non-carriers, and for subjects with higher levels of education. DISCUSSION: Our results support a 12–20 CL window for inclusion into early secondary prevention studies. Reliable accumulation definition warrants further investigations.
  •  
38.
  •  
39.
  • Bos, I., et al. (författare)
  • Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
  • 2019
  • Ingår i: Alzheimers & Dementia. - : Wiley. - 1552-5260 .- 1552-5279. ; 15:5, s. 644-654
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: We investigated relations between amyloid-beta (A beta) status, apolipoprotein E (APOE) e4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng), neurofilament light (NFL), YKL-40, and total tau (T-tau). Methods: We included 770 individuals with normal cognition, mild cognitive impairment, and Alzheimer's disease (AD)-type dementia from the EMIF-AD Multimodal Biomarker Discovery study. We tested the association of Ng, NFL, YKL-40, and T-tau with A beta status (Ab beta- vs. A beta+), clinical diagnosis APOE epsilon 4 carriership, baseline cognition, and change in cognition. Results: Ng and T-tau distinguished between A beta+ from A beta- individuals in each clinical group, whereas NFL and YKL-40 were associated with A beta+ in nondemented individuals only. APOE epsilon 4 carriership did not influence NFL, Ng, and YKL-40 in A beta+ individuals. NFL was the best predictor of cognitive decline in A beta+ individuals across the cognitive spectrum. Discussion: Axonal degeneration, synaptic dysfunction, astroglial activation, and altered tau metabolism are involved already in preclinical AD. NFL may be a useful prognostic marker. (C) 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
  •  
40.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-40 av 522
Typ av publikation
tidskriftsartikel (477)
konferensbidrag (32)
forskningsöversikt (13)
Typ av innehåll
refereegranskat (499)
övrigt vetenskapligt/konstnärligt (23)
Författare/redaktör
Zetterberg, Henrik, ... (154)
Blennow, Kaj, 1958 (140)
Hansson, Oskar (56)
Skoog, Ingmar, 1954 (33)
Ashton, Nicholas J. (33)
Ossenkoppele, Rik (30)
visa fler...
Scheltens, Philip (29)
Kivipelto, M (24)
Stomrud, Erik (24)
Soininen, Hilkka (23)
Schöll, Michael, 198 ... (23)
Blennow, Kaj (22)
Scheltens, P (21)
Teunissen, Charlotte ... (20)
Karikari, Thomas (20)
Zetterberg, Henrik (20)
Hampel, Harald (20)
Kivipelto, Miia (19)
Molinuevo, José Luis (19)
Visser, Pieter Jelle (19)
Tsolaki, Magda (18)
Barkhof, Frederik (18)
Wimo, A (18)
Winblad, B (17)
Soininen, H (16)
Palmqvist, Sebastian (16)
Engelborghs, Sebasti ... (16)
Fratiglioni, Laura (15)
van der Flier, Wiesj ... (15)
Frisoni, Giovanni B. (15)
Smith, Ruben (15)
Jonsson, L. (14)
Janelidze, Shorena (14)
Kern, Silke (14)
Mattsson-Carlgren, N ... (14)
Barkhof, F (14)
Xu, Weili (14)
Freund-Levi, Yvonne, ... (14)
Solomon, Alina (13)
Andreasson, Ulf, 196 ... (13)
Nordberg, Agneta (13)
Westman, E (12)
Wallin, Anders, 1950 (12)
Vandenberghe, Rik (12)
Winblad, Bengt (12)
Visser, PJ (12)
Frisoni, GB (12)
Martínez-Lage, Pablo (12)
Shaw, Leslie M (12)
Mattsson, Niklas (12)
visa färre...
Lärosäte
Göteborgs universitet (247)
Karolinska Institutet (231)
Lunds universitet (94)
Stockholms universitet (50)
Uppsala universitet (21)
Örebro universitet (16)
visa fler...
Umeå universitet (13)
Jönköping University (12)
Luleå tekniska universitet (10)
Linköpings universitet (8)
Linnéuniversitetet (5)
Högskolan Kristianstad (4)
Södertörns högskola (3)
Karlstads universitet (3)
Gymnastik- och idrottshögskolan (2)
Högskolan Dalarna (2)
Röda Korsets Högskola (2)
Kungliga Tekniska Högskolan (1)
Mittuniversitetet (1)
Högskolan i Skövde (1)
RISE (1)
Marie Cederschiöld högskola (1)
Sophiahemmet Högskola (1)
visa färre...
Språk
Engelska (522)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (391)
Samhällsvetenskap (9)
Naturvetenskap (8)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy